Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
PAMAM dendrimers functionalised with an anti-TNF α antibody and chondroitin sulphate for treatment of rheumatoid arthritis — Isabel Oliveira (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
PAMAM dendrimers functionalised with an anti-TNF α antibody and chondroitin sulphate for treatment of rheumatoid arthritis
Shared by
Rui L Reis
PAMAM dendrimers functionalised with an anti-TNF α antibody and chondroitin sulphate for treatment of rheumatoid arthritis
Article
2021
en
Authors
+5 more
IO
Isabel Oliveira
CG
Cristiana Gonçalves
EO
Eduarda P. Oliveira
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Guideline for anti-TNF-α therapy in psoriatic arthritis
Stuart Kyle
,
David Chandler
,
Christopher Em Griffiths
,
Philip Helliwell
,
James Lewis
,
Iain B. McInnes
,
S. Oliver
,
Deborah Symmons
,
Neil McHugh
Letter
2009
Graves’ Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy
Jae Il Shin
,
Min Jung Kim
,
Jae Seung Lee
Article
2014
AB0349 Significance of Positive Anti-Ccp Antibody and Development of Interstitial Lung Disease in Patients with and without Clinically Apparent Rheumatoid Arthritis
Muhammad Imran
,
Susan O’Brien
,
Michael R Hamblin
,
Mehrdad Maz
Article
2019
Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis
Amanda Pentecost
,
Min Ju Kim
,
Sangmin Jeon
,
Young Ji Ko
,
Ick Chan Kwon
,
Yury Gogotsi
,
Kwangmeyung Kim
,
Kara L. Spiller
Article
2023
Development of Conjugated Kefiran-Chondroitin Sulphate Cryogels with Enhanced Properties for Biomedical Applications
Hajer Radhouani
,
Cristiana Gonçalves
,
F. Raquel Maia
,
Eduarda P. Oliveira
,
Rui L Reis
,
Joaquím M. Oliveira
Discussion(0)
No comments yet. Be the first to comment.